Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in ASEAN is a dynamic and growing market, driven by various factors such as increasing population, rising healthcare awareness, and increasing government initiatives to improve healthcare infrastructure.
Customer preferences: Customers in ASEAN countries are becoming more aware of the benefits of using Other Pharmaceuticals, as they offer a range of treatments for various diseases and conditions. The increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases, is also driving the demand for Other Pharmaceuticals in the region.
Trends in the market: Indonesia and Thailand are the largest markets for Other Pharmaceuticals in ASEAN. In Indonesia, the market is driven by the increasing prevalence of chronic diseases, rising healthcare expenditure, and the growing middle class. In Thailand, the market is driven by the government's efforts to promote medical tourism and the increasing demand for alternative medicines.In the Philippines, the market for Other Pharmaceuticals is driven by the increasing demand for herbal and natural medicines. The country has a rich tradition of using traditional medicines, and this trend is expected to continue in the future. In Malaysia and Singapore, the market is driven by the increasing demand for dietary supplements and vitamins.
Local special circumstances: One of the unique features of the Other Pharmaceuticals market in ASEAN is the prevalence of traditional and herbal medicines. Many people in the region still rely on traditional medicines for their healthcare needs, and this trend is expected to continue in the future. The use of traditional medicines is also supported by the governments of many ASEAN countries, who recognize the importance of traditional medicines in their healthcare systems.
Underlying macroeconomic factors: The Other Pharmaceuticals market in ASEAN is also influenced by various macroeconomic factors such as population growth, increasing healthcare expenditure, and government initiatives to improve healthcare infrastructure. The increasing population in the region is driving the demand for healthcare services, including Other Pharmaceuticals. Governments in the region are also investing heavily in healthcare infrastructure, which is expected to boost the demand for Other Pharmaceuticals in the future.In conclusion, the Other Pharmaceuticals market in ASEAN is a growing and dynamic market, driven by various factors such as increasing population, rising healthcare awareness, and increasing government initiatives to improve healthcare infrastructure. The market is also influenced by local preferences for traditional and herbal medicines, which are supported by the governments of many ASEAN countries. Overall, the future of the Other Pharmaceuticals market in ASEAN looks bright, and it is expected to continue to grow in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
